{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T23:13:34Z","timestamp":1795216414304,"version":"4.10.3"},"reference-count":204,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2020YFA0908200"],"award-info":[{"award-number":["2020YFA0908200"]}]},{"name":"National Key Research and Development Program of China","award":["2020YFA0710800"],"award-info":[{"award-number":["2020YFA0710800"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930043"],"award-info":[{"award-number":["81930043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330055"],"award-info":[{"award-number":["82330055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2225003"],"award-info":[{"award-number":["T2225003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001719"],"award-info":[{"award-number":["82001719"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52073060"],"award-info":[{"award-number":["52073060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61927805"],"award-info":[{"award-number":["61927805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Jiangsu","award":["BE2018707"],"award-info":[{"award-number":["BE2018707"]}]},{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"publisher","award":["ZKX21019"],"award-info":[{"award-number":["ZKX21019"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Trials from Nanjing Drum Tower Hospital","award":["2022-LCYI-ZD-01"],"award-info":[{"award-number":["2022-LCYI-ZD-01"]}],"id":[{"id":"https:\/\/ror.org\/026axqv54","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04184-x","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T13:15:06Z","timestamp":1739279706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"16","author":[{"given":"Liuting","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuman","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensa","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"10","key":"4184_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41584-021-00652-9","volume":"17","author":"Z Szekanecz","year":"2021","unstructured":"Szekanecz Z, McInnes IB, Schett G, Szamosi S, Benk\u0151 S, Sz\u0171cs G. Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nat Rev Rheumatol. 2021;17(10):585\u201395. https:\/\/doi.org\/10.1038\/s41584-021-00652-9.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"4184_CR2","doi-asserted-by":"publisher","first-page":"103276","DOI":"10.1016\/j.autrev.2023.10327","volume":"22","author":"M Benucci","year":"2023","unstructured":"Benucci M, Bernardini P, Coccia C, De Luca R, Levani J, Economou A, Damiani A, Russo E, Amedei A, Guiducci S, Bartoloni E, Manfredi M, Grossi V, Infantino M, Perricone C. JAK inhibitors and autoimmune rheumatic diseases. Autoimmun Rev. 2023;22(4):103276. https:\/\/doi.org\/10.1016\/j.autrev.2023.10327.","journal-title":"Autoimmun Rev"},{"issue":"9894","key":"4184_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","volume":"382","author":"F Goldblatt","year":"2013","unstructured":"Goldblatt F, O\u2019Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet. 2013;382(9894):797\u2013808. https:\/\/doi.org\/10.1016\/S0140-6736(13)61499-3.","journal-title":"Lancet"},{"key":"4184_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.clim.2016.07.026","volume":"170","author":"P Coit","year":"2016","unstructured":"Coit P, Sawalha AH. The human microbiome in rheumatic autoimmune diseases: a comprehensive review. Clin Immunol. 2016;170:70\u20139. https:\/\/doi.org\/10.1016\/j.clim.2016.07.026.","journal-title":"Clin Immunol"},{"issue":"2","key":"4184_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrrheum.2017.220","volume":"14","author":"G Barturen","year":"2018","unstructured":"Barturen G, Beretta L, Cervera R, Van Vollenhoven R, Alarc\u00f3n-Riquelme ME. Moving towards a molecular taxonomy of autoimmune rheumatic diseases. Nat Rev Rheumatol. 2018;14(2):75\u201393. https:\/\/doi.org\/10.1038\/nrrheum.2017.220.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"4184_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103312","volume":"22","author":"FF Konen","year":"2023","unstructured":"Konen FF, M\u00f6hn N, Witte T, Schefzyk M, Wiestler M, Lovric S, Hufendiek K, Schwenkenbecher P, S\u00fchs KW, Friese MA, Klotz L, Pul R, Pawlitzki M, Hagin D, Kleinschnitz C, Meuth SG, Skripuletz T. Treatment of autoimmunity: the impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders. Autoimmun Rev. 2023;22(5): 103312. https:\/\/doi.org\/10.1016\/j.autrev.2023.103312.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"4184_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrrheum.2011.117","volume":"7","author":"L Davila","year":"2011","unstructured":"Davila L, Ranganathan P. Pharmacogenetics: implications for therapy in rheumatic diseases. Nat Rev Rheumatol. 2011;7(9):537\u201350. https:\/\/doi.org\/10.1038\/nrrheum.2011.117.","journal-title":"Nat Rev Rheumatol"},{"key":"4184_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.06.010","volume":"103","author":"JI Shin","year":"2019","unstructured":"Shin JI, Lee KH, Joo YH, Lee JM, Jeon J, Jung HJ, Shin M, Cho S, Kim TH, Park S, Jeon BY, Jeong H, Lee K, Kang K, Oh M, Lee H, Lee S, Kwon Y, Oh GH, Kronbichler A. Inflammasomes and autoimmune and rheumatic diseases: a comprehensive review. J Autoimmun. 2019;103: 102299. https:\/\/doi.org\/10.1016\/j.jaut.2019.06.010.","journal-title":"J Autoimmun"},{"issue":"8","key":"4184_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41584-020-0463-8","volume":"16","author":"S Onuora","year":"2020","unstructured":"Onuora S. New data emerging on outcomes for patients with COVID-19 and rheumatic diseases. Nat Rev Rheumatol. 2020;16(8):407. https:\/\/doi.org\/10.1038\/s41584-020-0463-8.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"4184_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103359","volume":"22","author":"F Cao","year":"2023","unstructured":"Cao F, Liu YC, Ni QY, Chen Y, Wan CH, Liu SY, Tao LM, Jiang ZX, Ni J, Pan HF. Temporal trends in the prevalence of autoimmune diseases from 1990 to 2019. Autoimmun Rev. 2023;22(8): 103359. https:\/\/doi.org\/10.1016\/j.autrev.2023.103359.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"4184_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nrrheum.2011.2","volume":"7","author":"RR Edwards","year":"2011","unstructured":"Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA. Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol. 2011;7(4):216\u201324. https:\/\/doi.org\/10.1038\/nrrheum.2011.2.","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"4184_CR12","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.3390\/cells10123592","volume":"10","author":"AE Gracia-Ramos","year":"2021","unstructured":"Gracia-Ramos AE, Martin-Nares E, Hern\u00e1ndez-Molina G. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis. Cells. 2021;10(12):3592. https:\/\/doi.org\/10.3390\/cells10123592.","journal-title":"Cells"},{"issue":"12","key":"4184_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41584-020-00522-w","volume":"16","author":"X Bossuyt","year":"2020","unstructured":"Bossuyt X, De Langhe E, Borghi MO, Meroni PL. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases. Nat Rev Rheumatol. 2020;16(12):715\u201326. https:\/\/doi.org\/10.1038\/s41584-020-00522-w.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"4184_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrrheum.2015.138","volume":"11","author":"JD Isaacs","year":"2015","unstructured":"Isaacs JD. Decade in review-clinical rheumatology: 10 years of therapeutic advances in the rheumatic diseases. Nat Rev Rheumatol. 2015;11(11):628\u201330. https:\/\/doi.org\/10.1038\/nrrheum.2015.138.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4184_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149675","volume":"53","author":"A Merino-Vico","year":"2023","unstructured":"Merino-Vico A, Frazzei G, van Hamburg JP, Tas SW. Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches. Eur J Immunol. 2023;53(1): e2149675. https:\/\/doi.org\/10.1002\/eji.202149675.","journal-title":"Eur J Immunol"},{"issue":"7","key":"4184_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrrheum.2017.95","volume":"13","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Bijlsma JWJ, Cutolo M, McInnes IB. Managing rheumatic and musculoskeletal diseases - past, present and future. Nat Rev Rheumatol. 2017;13(7):443\u20138. https:\/\/doi.org\/10.1038\/nrrheum.2017.95.","journal-title":"Nat Rev Rheumatol"},{"issue":"10416","key":"4184_CR17","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126","volume":"402","author":"G Schett","year":"2023","unstructured":"Schett G, Mackensen A, Mougiakakos D. CAR T-cell therapy in autoimmune diseases. Lancet. 2023;402(10416):2034\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(23)01126.","journal-title":"Lancet"},{"issue":"9","key":"4184_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41584-024-01139-z","volume":"20","author":"G Schett","year":"2024","unstructured":"Schett G, M\u00fcller F, Taubmann J, Mackensen A, Wang W, Furie RA, Gold R, Haghikia A, Merkel PA, Caricchio R, D\u2019Agostino MA, Locatelli F, June CH, Mougiakakos D. Advancements and challenges in CAR T cell therapy in autoimmune diseases. Nat Rev Rheumatol. 2024;20(9):531\u201344. https:\/\/doi.org\/10.1038\/s41584-024-01139-z.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4184_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","volume":"14","author":"A Lotfy","year":"2023","unstructured":"Lotfy A, AboQuella NM, Wang H. Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther. 2023;14(1):66. https:\/\/doi.org\/10.1186\/s13287-023-03287-7.","journal-title":"Stem Cell Res Ther"},{"key":"4184_CR20","doi-asserted-by":"publisher","first-page":"9463314","DOI":"10.1155\/2022\/9463314","volume":"2022","author":"L Zeng","year":"2022","unstructured":"Zeng L, Yu G, Yang K, Xiang W, Li J, Chen H. Efficacy and safety of mesenchymal stem cell transplantation in the treatment of autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, and ankylosing spondylitis): a systematic review and meta-analysis of randomized controlled trial. Stem Cells Int. 2022;2022:9463314. https:\/\/doi.org\/10.1155\/2022\/9463314.","journal-title":"Stem Cells Int"},{"key":"4184_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.631291","volume":"12","author":"JJ Hwang","year":"2021","unstructured":"Hwang JJ, Rim YA, Nam Y, Ju JH. Recent developments in clinical applications of mesenchymal stem cells in the treatment of rheumatoid arthritis and osteoarthritis. Front Immunol. 2021;12: 631291. https:\/\/doi.org\/10.3389\/fimmu.2021.631291.","journal-title":"Front Immunol"},{"key":"4184_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.833878","volume":"13","author":"R Wu","year":"2022","unstructured":"Wu R, Fan X, Wang Y, Shen M, Zheng Y, Zhao S, Yang L. Mesenchymal Stem Cell-Derived Extracellular Vesicles in Liver Immunity and Therapy. Front Immunol. 2022;13: 833878. https:\/\/doi.org\/10.3389\/fimmu.2022.833878.","journal-title":"Front Immunol"},{"issue":"1","key":"4184_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/annrheumdis-2022-222574","volume":"82","author":"MHA Jansen","year":"2023","unstructured":"Jansen MHA, Rondaan C, Legger GE, Minden K, Uziel Y, Toplak N, Maritsi D, van den Berg L, Berbers GAM, Bruijning P, Egert Y, Normand C, Bijl M, Foster HE, Kon\u00e9-Paut I, Wouters C, Ravelli A, Elkayam O, Wulffraat NM, Heijstek MW. EULAR\/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Ann Rheum Dis. 2023;82(1):35\u201347. https:\/\/doi.org\/10.1136\/annrheumdis-2022-222574.","journal-title":"Ann Rheum Dis"},{"key":"4184_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.749192","volume":"12","author":"Z Shen","year":"2021","unstructured":"Shen Z, Huang W, Liu J, Tian J, Wang S, Rui K. Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases. Front Immunol. 2021;12: 749192. https:\/\/doi.org\/10.3389\/fimmu.2021.749192.","journal-title":"Front Immunol"},{"issue":"11","key":"4184_CR25","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10067-014-2754-4","volume":"33","author":"F Gu","year":"2014","unstructured":"Gu F, Wang D, Zhang H, Feng X, Gilkeson GS, Shi S, Sun L. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy. Clin Rheumatol. 2014;33(11):1611\u20139. https:\/\/doi.org\/10.1007\/s10067-014-2754-4.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4184_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00005-021-00603-y","volume":"69","author":"WY Tang","year":"2021","unstructured":"Tang WY, Liu JH, Peng CJ, Liao Y, Luo JS, Sun X, Tang YL, Luo XQ. Functional characteristics and application of mesenchymal stem cells in systemic lupus erythematosus. Arch Immunol Ther Exp (Warsz). 2021;69(1):7. https:\/\/doi.org\/10.1007\/s00005-021-00603-y.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"7","key":"4184_CR27","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1177\/0961203318768889","volume":"27","author":"A Fathollahi","year":"2018","unstructured":"Fathollahi A, Gabalou NB, Aslani S. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder. Lupus. 2018;27(7):1053\u201364. https:\/\/doi.org\/10.1177\/0961203318768889.","journal-title":"Lupus"},{"issue":"11","key":"4184_CR28","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/stmcls\/sxac057","volume":"40","author":"S Fujii","year":"2022","unstructured":"Fujii S, Miura Y. Immunomodulatory and regenerative effects of MSC-derived extracellular vesicles to treat acute GVHD. Stem Cells. 2022;40(11):977\u201390. https:\/\/doi.org\/10.1093\/stmcls\/sxac057.","journal-title":"Stem Cells"},{"issue":"3","key":"4184_CR29","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.stemcr.2018.01.029","volume":"10","author":"D Wang","year":"2018","unstructured":"Wang D, Zhang H, Liang J, Wang H, Hua B, Feng X, Gilkeson GS, Farge D, Shi S, Sun L. A long-term follow-up study of allogeneic mesenchymal stem\/stromal cell transplantation in patients with drug-resistant systemic lupus erythematosus. Stem Cell Reports. 2018;10(3):933\u201341. https:\/\/doi.org\/10.1016\/j.stemcr.2018.01.029.","journal-title":"Stem Cell Reports"},{"issue":"11","key":"4184_CR30","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41584-023-01010-7","volume":"19","author":"GM Bertolino","year":"2023","unstructured":"Bertolino GM, Maumus M, Jorgensen C, No\u00ebl D. Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells. Nat Rev Rheumatol. 2023;19(11):682\u201394. https:\/\/doi.org\/10.1038\/s41584-023-01010-7.","journal-title":"Nat Rev Rheumatol"},{"key":"4184_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.728190","volume":"12","author":"A Li","year":"2021","unstructured":"Li A, Guo F, Pan Q, Chen S, Chen J, Liu HF, Pan Q. Mesenchymal stem cell therapy: hope for patients with systemic lupus erythematosus. Front Immunol. 2021;12: 728190. https:\/\/doi.org\/10.3389\/fimmu.2021.728190.","journal-title":"Front Immunol"},{"issue":"1","key":"4184_CR32","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13287-018-1053-4","volume":"9","author":"J Liang","year":"2018","unstructured":"Liang J, Zhang H, Kong W, Deng W, Wang D, Feng X, Zhao C, Hua B, Wang H, Sun L. Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study. Stem Cell Res Ther. 2018;9(1):312. https:\/\/doi.org\/10.1186\/s13287-018-1053-4.","journal-title":"Stem Cell Res Ther"},{"key":"4184_CR33","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JJ Deeks","year":"2020","unstructured":"Deeks JJ, Higgins JP, Altman DG. Chapter 16: special topics in statistics. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. UK: The Cochrane Collaboration; 2020."},{"key":"4184_CR34","unstructured":"Deeks JJ, Higgins JP, Altman DG.: Chapter 8: assessing risk of bias in included studies. In: Higgins JP Green S, editors. Cochrane Handbook or Systematic Reviews of Interventions Version 6.1.0. UK: The Cochrane Collaboration; 2020."},{"key":"4184_CR35","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JJ Deeks","year":"2020","unstructured":"Deeks JJ, Higgins JP, Altman DG. Chapter 9: Analyzing data and undertaking meta-analyses. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. UK: The Cochrane Collaboration; 2020."},{"issue":"03","key":"4184_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3969\/j.issn.1674-4659.2020.03.0295","volume":"27","author":"SU Hongjun","year":"2020","unstructured":"Hongjun SU, Wen DENG, Pei FENG. Analysis of the effect of umbilical cord mesenchymal stem cell transplantation in the treatment of patients with ankylosing spondylitis[J]. Clinical Medical Engineering. 2020;27(03):295\u20136. https:\/\/doi.org\/10.3969\/j.issn.1674-4659.2020.03.0295.","journal-title":"Clinical Medical Engineering"},{"issue":"1","key":"4184_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12967-018-1541-4","volume":"16","author":"Y Yang","year":"2018","unstructured":"Yang Y, He X, Zhao R, Guo W, Zhu M, Xing W, Jiang D, Liu C, Xu X. Serum IFN-\u03b3 levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis. J Transl Med. 2018;16(1):165. https:\/\/doi.org\/10.1186\/s12967-018-1541-4.","journal-title":"J Transl Med"},{"issue":"1","key":"4184_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","volume":"76","author":"JM \u00c1lvaro-Gracia","year":"2017","unstructured":"\u00c1lvaro-Gracia JM, Jover JA, Garc\u00eda-Vicu\u00f1a R, Carre\u00f1o L, Alonso A, Marsal S, Blanco F, Mart\u00ednez-Taboada VM, Taylor P, Mart\u00edn-Mart\u00edn C, DelaRosa O, Tagarro I, D\u00edaz-Gonz\u00e1lez F. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib\/IIa clinical trial. Ann Rheum Dis. 2017;76(1):196\u2013202. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208918.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4184_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jcyt.2017.12.009","volume":"20","author":"S Shadmanfar","year":"2018","unstructured":"Shadmanfar S, Labibzadeh N, Emadedin M, Jaroughi N, Azimian V, Mardpour S, Kakroodi FA, Bolurieh T, Hosseini SE, Chehrazi M, Niknejadi M, Baharvand H, Gharibdoost F, Aghdami N. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: results of a randomized, triple-blind, placebo-controlled phase 1\/2 clinical trial. Cytotherapy. 2018;20(4):499\u2013506. https:\/\/doi.org\/10.1016\/j.jcyt.2017.12.009.","journal-title":"Cytotherapy"},{"issue":"8","key":"4184_CR40","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/art.42133","volume":"74","author":"D Khanna","year":"2022","unstructured":"Khanna D, Caldron P, Martin RW, Kafaja S, Spiera R, Shahouri S, Shah A, Hsu V, Ervin J, Simms R, Domsic RT, Steen V, Hummers LK, Derk C, Mayes M, Chatterjee S, Varga J, Kesten S, Fraser JK, Furst DE. Adipose-derived regenerative cell transplantation for the treatment of hand dysfunction in systemic sclerosis: a randomized clinical trial. Arthritis Rheumatol. 2022;74(8):1399\u2013408. https:\/\/doi.org\/10.1002\/art.42133.","journal-title":"Arthritis Rheumatol"},{"issue":"01","key":"4184_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.16048\/j.issn.2095-5561.2022.01.03","volume":"10","author":"S Yue","year":"2022","unstructured":"Yue S, Xinwei L, Lei XD, et al. Research on the efficacy of human umbilical cord blood mesenchymal stem cells in the treatment of knee osteoarthritis. Trauma and Critical Care Medicine. 2022;10(01):7\u201310. https:\/\/doi.org\/10.16048\/j.issn.2095-5561.2022.01.03.","journal-title":"Trauma and Critical Care Medicine"},{"issue":"1","key":"4184_CR42","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12967-020-02530-6","volume":"18","author":"JM Lamo-Espinosa","year":"2020","unstructured":"Lamo-Espinosa JM, Blanco JF, S\u00e1nchez M, Moreno V, Granero-Molt\u00f3 F, S\u00e1nchez-Guijo F, Crespo-Cullel \u00cd, Mora G, San Vicente DD, Pompei-Fern\u00e1ndez O, Aquerreta JD, N\u00fa\u00f1ez-C\u00f3rdoba JM, Vitoria Sola M, Valent\u00ed-Azc\u00e1rate A, Andreu EJ, Ca\u00f1izo DCD, M, Valent\u00ed-Nin JR, Pr\u00f3sper F. Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis. J Transl Med. 2020;18(1):356. https:\/\/doi.org\/10.1186\/s12967-020-02530-6.","journal-title":"J Transl Med"},{"issue":"3","key":"4184_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2217\/rme-2018-0161","volume":"14","author":"J Freitag","year":"2019","unstructured":"Freitag J, Bates D, Wickham J, Shah K, Huguenin L, Tenen A, Paterson K, Boyd R. Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regen Med. 2019;14(3):213\u201330. https:\/\/doi.org\/10.2217\/rme-2018-0161.","journal-title":"Regen Med"},{"key":"4184_CR44","doi-asserted-by":"publisher","DOI":"10.27272\/d.cnki.gshdu.2020.004899","author":"Z Meng","year":"2021","unstructured":"Meng Z. Clinical study of autologous adipose mesenchymal stem cells combined with high tibial osteotomy for the treatment of osteoarthritis of the knee joint. Shandong Univ. 2021. https:\/\/doi.org\/10.27272\/d.cnki.gshdu.2020.004899.","journal-title":"Shandong Univ"},{"issue":"2","key":"4184_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2106\/JBJS.M.00058","volume":"96","author":"CT Vangsness Jr","year":"2014","unstructured":"Vangsness CT Jr, Jack Farr II, Boyd J, Dellaero DT, Mills CR, LeRoux-Williams M. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. JBJS. 2014;96(2):90\u20138. https:\/\/doi.org\/10.2106\/JBJS.M.00058.","journal-title":"JBJS"},{"issue":"3","key":"4184_CR46","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/0363546519899923","volume":"48","author":"JR Garza","year":"2020","unstructured":"Garza JR, Campbell RE, Tjoumakaris FP, Freedman KB, Miller LS, Santa Maria D, Tucker BS. Clinical efficacy of intra-articular mesenchymal stromal cells for the treatment of knee osteoarthritis: a double-blinded prospective randomized controlled clinical trial. Am J Sports Med. 2020;48(3):588\u201398. https:\/\/doi.org\/10.1177\/0363546519899923.","journal-title":"Am J Sports Med"},{"issue":"5","key":"4184_CR47","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3877\/cma.j.issn.1674-134X.2018.05.009","volume":"12","author":"HA Chengzhi","year":"2018","unstructured":"Chengzhi HA, Wei LI, Shaoda REN, et al. Efficacy of platelet-rich plasma combined with mesenchymal stem cells in the treatment of knee osteoarthritis. Chinese J Joint Surg (Electron Ed). 2018;12(5):644\u201352. https:\/\/doi.org\/10.3877\/cma.j.issn.1674-134X.2018.05.009.","journal-title":"Chinese J Joint Surg (Electron Ed)"},{"key":"4184_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1591-7","author":"JM Lamo-Espinosa","year":"2018","unstructured":"Lamo-Espinosa JM, Mora G, Blanco JF, Granero-Molt\u00f3 F, N\u00fa\u00f1ez-C\u00f3rdoba JM, L\u00f3pez-El\u00edo S, Andreu E, S\u00e1nchez-Guijo F, Aquerreta JD, Bond\u00eda JM, Valent\u00ed-Azc\u00e1rate A, del Consuelo M, del Ca\u00f1izo E, Villar\u00f3n M, Valent\u00ed-Nin JR, Pr\u00f3sper F. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I\/II). J Translat Med. 2018. https:\/\/doi.org\/10.1186\/s12967-018-1591-7.","journal-title":"J Translat Med"},{"issue":"5","key":"4184_CR49","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00264-018-4099-0","volume":"43","author":"Z Hong","year":"2019","unstructured":"Hong Z, Chen J, Zhang S, Zhao C, Bi M, Chen X, Bi Q. Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial. Int Orthop. 2019;43(5):1123\u201334. https:\/\/doi.org\/10.1007\/s00264-018-4099-0.","journal-title":"Int Orthop"},{"issue":"1","key":"4184_CR50","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1186\/s13287-021-02631-z","volume":"12","author":"CF Chen","year":"2021","unstructured":"Chen CF, Hu CC, Wu CT, Wu HH, Chang CS, Hung YP, Tsai CC, Chang Y. Treatment of knee osteoarthritis with intra-articular injection of allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE\u00ae: a phase I\/II, randomized, active-control, single-blind, multiple-center clinical trial. Stem Cell Res Ther. 2021;12(1):562. https:\/\/doi.org\/10.1186\/s13287-021-02631-z.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"4184_CR51","first-page":"28","volume":"5","author":"Lv Xiaoxia","year":"2015","unstructured":"Xiaoxia Lv, Cheng H, Zhi Y, et al. Observation on the efficacy of autologous bone marrow mesenchymal stem cell transplantation in osteoarthritis of the knee. Chinese J Cells Stem Cells (Electron Ed). 2015;5(2):28\u201332.","journal-title":"Chinese J Cells Stem Cells (Electron Ed)"},{"key":"4184_CR52","doi-asserted-by":"publisher","unstructured":"Wong KL, Lee KB, Tai BC, Law P, Lee EH, Hui JH. Injectable cultured bone marrow\u2013derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 Years' follow-up. Arthroscopy: The Journal of Arthroscopic and Related Surgery. 2013;29(12):2020-8..https:\/\/doi.org\/10.1016\/j.arthro.2013.09.074.","DOI":"10.1016\/j.arthro.2013.09.074"},{"issue":"1","key":"4184_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13287-019-1248-3","volume":"10","author":"L Lu","year":"2019","unstructured":"Lu L, Dai C, Zhang Z, Du H, Li S, Ye P, Fu Q, Zhang L, Wu X, Dong Y, Song Y, Zhao D, Pang Y, Bao C. Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial. Stem Cell Res Ther. 2019;10(1):143. https:\/\/doi.org\/10.1186\/s13287-019-1248-3.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"4184_CR54","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.7507\/1002-1892.20160305","volume":"30","author":"WANG Yali","year":"2016","unstructured":"Yali WANG, Wenxiao JIN, Haiyan LIU, et al. Observation on the efficacy of articular cavity injection of human umbilical cord MSCs in the treatment of degenerative knee osteoarthritis[J]. Chinese J Repair Reconstr Surg. 2016;30(12):1472\u20137. https:\/\/doi.org\/10.7507\/1002-1892.20160305.","journal-title":"Chinese J Repair Reconstr Surg"},{"key":"4184_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-016-1195-7","volume":"18","author":"PK Gupta","year":"2016","unstructured":"Gupta PK, Chullikana A, Rengasamy M, Shetty N, Pandey V, Agarwal V, Wagh SY, Vellotare PK, Damodaran D, Viswanathan P, Thej C. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel\u00ae): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Therapy. 2016;18:1\u20138. https:\/\/doi.org\/10.1186\/s13075-016-1195-7.","journal-title":"Arthritis Res Therapy"},{"issue":"8","key":"4184_CR56","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1097\/TP.0000000000000678","volume":"99","author":"A Vega","year":"2015","unstructured":"Vega A, Mart\u00edn-Ferrero MA, Del Canto F, Alberca M, Garc\u00eda V, Munar A, Orozco L, Soler R, Fuertes JJ, Huguet M, S\u00e1nchez A, Garc\u00eda-Sancho J. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015;99(8):1681\u201390. https:\/\/doi.org\/10.1097\/TP.0000000000000678.","journal-title":"Transplantation"},{"key":"4184_CR57","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s00264-018-3916-9","volume":"42","author":"P Hernigou","year":"2018","unstructured":"Hernigou P, Auregan JC, Dubory A, Flouzat-Lachaniette CH, Chevallier N, Rouard H. Subchondral stem cell therapy versus contralateral total knee arthroplasty for osteoarthritis following secondary osteonecrosis of the knee. Int Orthopaedics. 2018;42:2563\u201371. https:\/\/doi.org\/10.1007\/s00264-018-3916-9.","journal-title":"Int Orthopaedics."},{"issue":"23","key":"4184_CR58","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3760\/cma.j.issn.0253-2352.2018.23.002","volume":"38","author":"ZHANG Sheng-Yang","year":"2018","unstructured":"Sheng-Yang ZHANG, Shuai-Jie LU, Authoritative DING, et al. A randomised controlled study of autologous adipose stem cell intra-articular injection for the treatment of knee osteoarthritis. Chinese J Orthopaedics. 2018;38(23):1426\u201334. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2352.2018.23.002.","journal-title":"Chinese J Orthopaedics"},{"issue":"6","key":"4184_CR59","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/sctm.18-0122","volume":"8","author":"WS Lee","year":"2019","unstructured":"Lee WS, Kim HJ, Kim KI, Kim GB, Jin W. Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial. Stem Cells Transl Med. 2019;8(6):504\u201311. https:\/\/doi.org\/10.1002\/sctm.18-0122.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"4184_CR60","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcyt.2018.11.003","volume":"21","author":"S Khalifeh Soltani","year":"2019","unstructured":"Khalifeh Soltani S, Forogh B, Ahmadbeigi N, Hadizadeh Kharazi H, Fallahzadeh K, Kashani L, Karami M, Kheyrollah Y, Vasei M. Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study. Cytotherapy. 2019;21(1):54\u201363. https:\/\/doi.org\/10.1016\/j.jcyt.2018.11.003.","journal-title":"Cytotherapy"},{"issue":"3","key":"4184_CR61","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/sctm.18-0053","volume":"8","author":"J Matas","year":"2019","unstructured":"Matas J, Orrego M, Amenabar D, Infante C, Tapia-Limonchi R, Cadiz MI, Alcayaga-Miranda F, Gonz\u00e1lez PL, Muse E, Khoury M, Figueroa FE, Espinoza F. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I\/II trial. Stem Cells Transl Med. 2019;8(3):215\u201324. https:\/\/doi.org\/10.1002\/sctm.18-0053.","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"4184_CR62","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00167-019-05732-8","volume":"28","author":"R Bastos","year":"2020","unstructured":"Bastos R, Mathias M, Andrade R, Amaral RJFC, Schott V, Balduino A, Bastos R, Miguel Oliveira J, Reis RL, Rodeo S, Espregueira-Mendes J. Intra-articular injection of culture-expanded mesenchymal stem cells with or without addition of platelet-rich plasma is effective in decreasing pain and symptoms in knee osteoarthritis: a controlled, double-blind clinical trial. Knee Surg Sports Traumatol Arthrosc. 2020;28(6):1989\u201399. https:\/\/doi.org\/10.1007\/s00167-019-05732-8.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"1","key":"4184_CR63","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13287-023-03359-8","volume":"14","author":"B Sadri","year":"2023","unstructured":"Sadri B, Hassanzadeh M, Bagherifard A, Mohammadi J, Alikhani M, Moeinabadi-Bidgoli K, Madani H, Diaz-Solano D, Karimi S, Mehrazmay M, Mohammadpour M, Vosough M. Cartilage regeneration and inflammation modulation in knee osteoarthritis following injection of allogeneic adipose-derived mesenchymal stromal cells: a phase II, triple-blinded, placebo controlled, randomized trial. Stem Cell Res Ther. 2023;14(1):162. https:\/\/doi.org\/10.1186\/s13287-023-03359-8.","journal-title":"Stem Cell Res Ther"},{"key":"4184_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-018-1420-z","volume":"16","author":"D Kuah","year":"2018","unstructured":"Kuah D, Sivell S, Longworth T, James K, Guermazi A, Cicuttini F, Wang Y, Craig S, Comin G, Robinson D, Wilson J. Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study. J Translat Med. 2018;16:1\u20133. https:\/\/doi.org\/10.1186\/s12967-018-1420-z.","journal-title":"J Translat Med"},{"issue":"2","key":"4184_CR65","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00264-020-04571-4","volume":"45","author":"P Hernigou","year":"2021","unstructured":"Hernigou P, Delambre J, Quiennec S, Poignard A. Human bone marrow mesenchymal stem cell injection in subchondral lesions of knee osteoarthritis: a prospective randomized study versus contralateral arthroplasty at a mean fifteen year follow-up. Int Orthop. 2021;45(2):365\u201373. https:\/\/doi.org\/10.1007\/s00264-020-04571-4.","journal-title":"Int Orthop"},{"issue":"8","key":"4184_CR66","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/annrheumdis-2017-211073","volume":"76","author":"D Deng","year":"2017","unstructured":"Deng D, Zhang P, Guo Y, Lim TO. A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis. Ann Rheum Dis. 2017;76(8):1436\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211073.","journal-title":"Ann Rheum Dis"},{"issue":"02","key":"4184_CR67","first-page":"338","volume":"45","author":"Y Guixian","year":"2014","unstructured":"Guixian Y, Liping P, Qiaoyan Z, Wei S, Zhiqin C, Wang Chengxiao Wu, Yanbo WH, Qiang C. Efficacy of umbilical cord mesenchymal stem cell transplantation in the adjuvant treatment of systemic lupus erythematosus. J Sichuan Univ (Med Ed). 2014;45(02):338\u201341.","journal-title":"J Sichuan Univ (Med Ed)"},{"issue":"5","key":"4184_CR68","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.3892\/etm.2016.3724","volume":"12","author":"J Hu","year":"2016","unstructured":"Hu J, Zhao G, Zhang L, Qiao C, Di A, Gao H, Xu H. Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis. Exp Ther Med. 2016;12(5):2983\u20139. https:\/\/doi.org\/10.3892\/etm.2016.3724.","journal-title":"Exp Ther Med"},{"key":"4184_CR69","doi-asserted-by":"publisher","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Leselbaum A, Danese S; ADMIRE CD Study Group Collaborators. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016; 388(10051):1281\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(16)31203-X.","DOI":"10.1016\/S0140-6736(16)31203-X"},{"issue":"4","key":"4184_CR70","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","volume":"149","author":"I Molendijk","year":"2015","unstructured":"Molendijk I, Bonsing BA, Roelofs H, Peeters KC, Wasser MN, Dijkstra G, van der Woude CJ, Duijvestein M, Veenendaal RA, Zwaginga JJ, Verspaget HW, Fibbe WE, van der Meulen-de Jong AE, Hommes DW. Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology. 2015;149(4):918\u201327. https:\/\/doi.org\/10.1053\/j.gastro.2015.06.014.","journal-title":"Gastroenterology"},{"issue":"1","key":"4184_CR71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","volume":"52","author":"D Garcia-Olmo","year":"2009","unstructured":"Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De-La-Quintana P, Garcia-Arranz M, Pascual M. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum. 2009;52(1):79\u201386. https:\/\/doi.org\/10.1007\/DCR.0b013e3181973487.","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"4184_CR72","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.msard.2014.08.002","volume":"3","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Bowen JD, Huddlestone J, Kremenchutzky M, Carpenter A, Corboy JR, Freedman MS, Krupp L, Paulo C, Hariri RJ, Fischkoff SA. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Mult Scler Relat Disord. 2014;3(6):696\u2013704. https:\/\/doi.org\/10.1016\/j.msard.2014.08.002.","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"4184_CR73","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1093\/brain\/awaa333","volume":"143","author":"P Petrou","year":"2020","unstructured":"Petrou P, Kassis I, Levin N, Paul F, Backner Y, Benoliel T, Oertel FC, Scheel M, Hallimi M, Yaghmour N, Hur TB, Ginzberg A, Levy Y, Abramsky O, Karussis D. Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain. 2020;143(12):3574\u201388. https:\/\/doi.org\/10.1093\/brain\/awaa333.","journal-title":"Brain"},{"issue":"12","key":"4184_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113936","volume":"9","author":"S Llufriu","year":"2014","unstructured":"Llufriu S, Sep\u00falveda M, Blanco Y, Mar\u00edn P, Moreno B, Berenguer J, Gabilondo I, Mart\u00ednez-Heras E, Sola-Valls N, Arnaiz JA, Andreu EJ, Fern\u00e1ndez B, Bullich S, S\u00e1nchez-Dalmau B, Graus F, Villoslada P, Saiz A. Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis. PLoS ONE. 2014;9(12): e113936. https:\/\/doi.org\/10.1371\/journal.pone.0113936.","journal-title":"PLoS ONE"},{"issue":"5","key":"4184_CR75","doi-asserted-by":"publisher","first-page":"e0195891","DOI":"10.1371\/journal.pone.0195891","volume":"13","author":"O Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez O, Izquierdo G, Fern\u00e1ndez V, Leyva L, Reyes V, Guerrero M, Le\u00f3n A, Arnaiz C, Navarro G, P\u00e1ramo MD, Cuesta A, Soria B, Hmadcha A, Pozo D, Fernandez-Montesinos R, Leal M, Ochotorena I, G\u00e1lvez P, Geniz MA, Bar\u00f3n FJ, Mata R, Medina C, Caparr\u00f3s-Escudero C, Cardesa A, Cuende N. Research group study EudraCT 2008\u2013004015\u201335. Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: a triple blinded, placebo controlled, randomized phase I\/II safety and feasibility study. PLoS ONE. 2018;13(5):e0195891. https:\/\/doi.org\/10.1371\/journal.pone.0195891.","journal-title":"PLoS ONE"},{"key":"4184_CR76","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.3727\/096368914X685005","volume":"23","author":"JF Li","year":"2014","unstructured":"Li JF, Zhang DJ, Geng T, Chen L, Huang H, Yin HL, Zhang YZ, Lou JY, Cao B, Wang YL. The potential of human umbilical cord-derived mesenchymal stem cells as a novel cellular therapy for multiple sclerosis. Cell Transplant. 2014;23:S113\u201322. https:\/\/doi.org\/10.3727\/096368914X685005.","journal-title":"Cell Transplant"},{"issue":"1","key":"4184_CR77","doi-asserted-by":"publisher","first-page":"13521","DOI":"10.1038\/s41598-023-40802-5","volume":"13","author":"F Li","year":"2023","unstructured":"Li F, Lu J, Shi X, Li D, Zhou T, Jiang T, Wang S. Effect of adipose tissue-derived stem cells therapy on clinical response in patients with primary Sjogren\u2019s syndrome. Sci Rep. 2023;13(1):13521. https:\/\/doi.org\/10.1038\/s41598-023-40802-5.","journal-title":"Sci Rep"},{"issue":"18","key":"4184_CR78","doi-asserted-by":"publisher","first-page":"27","DOI":"10.19589\/j.cnki.issn1004-6569.2019.18.027","volume":"28","author":"Y Fan","year":"2019","unstructured":"Fan Y. Microfracture plus bone marrow mesenchymal stem cell transplantation for knee cartilage injury. Biped Health Care. 2019;28(18):27\u20138. https:\/\/doi.org\/10.19589\/j.cnki.issn1004-6569.2019.18.027.","journal-title":"Biped Health Care"},{"issue":"09","key":"4184_CR79","first-page":"1","volume":"9","author":"HL Liang","year":"2015","unstructured":"Liang HL, Huang K, Li L, Cai M, Huang JC, Long TF, Yang W, Liang F, Liu L. Arthroscopic microfracture surgery combined with autologous bone marrow mesenchymal stem cell transplantation for knee cartilage defects. China Modern Drug Appl. 2015;9(09):1\u20133.","journal-title":"China Modern Drug Appl"},{"key":"4184_CR80","doi-asserted-by":"publisher","DOI":"10.26988\/d.cnki.gcdzu.2020.000388","author":"Li Wenhan","year":"2020","unstructured":"Wenhan Li. Clinical study of delayed pain after intra-articular injection of mesenchymal stem cells in patients with knee osteoarthritis by Emei school of injury manipulation intervention. Chengdu Univ Tradit Chinese Med. 2020. https:\/\/doi.org\/10.26988\/d.cnki.gcdzu.2020.000388.","journal-title":"Chengdu Univ Tradit Chinese Med"},{"issue":"25","key":"4184_CR81","doi-asserted-by":"publisher","first-page":"75","DOI":"10.14163\/j.cnki.11-5547\/r.2020.25.033","volume":"15","author":"Z Ting","year":"2020","unstructured":"Ting Z, Songlou Y, Hanqiu Y. Effectiveness and mechanism of mesenchymal stem cells in the treatment of osteoarthritis. China Pract Med. 2020;15(25):75\u20136. https:\/\/doi.org\/10.14163\/j.cnki.11-5547\/r.2020.25.033.","journal-title":"China Pract Med"},{"issue":"20","key":"4184_CR82","first-page":"80","volume":"27","author":"L Xunzhi","year":"2020","unstructured":"Xunzhi L, Huabin He, Weiwei X, Cheng He. Clinical effects of combined autologous fat and synovial mesenchymal stem cells in the treatment of knee osteoarthritis. Chinese Contemp Med. 2020;27(20):80\u20133.","journal-title":"Chinese Contemp Med"},{"issue":"09","key":"4184_CR83","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.13429\/j.cnki.cjcr.2018.09.020","volume":"31","author":"ZQ Chen","year":"2018","unstructured":"Chen ZQ, Liu Shun G, Liu Y, Gong TF. Efficacy of intra-articular cavity injection of synovial-derived mesenchymal stem cells on knee cartilage injury. China Clinical Res. 2018;31(09):1232\u20135. https:\/\/doi.org\/10.13429\/j.cnki.cjcr.2018.09.020.","journal-title":"China Clinical Res"},{"issue":"09","key":"4184_CR84","first-page":"1407","volume":"22","author":"ZY Yang","year":"2018","unstructured":"Yang ZY, Lin JH, Xing D, Wang B, Hou YF. Clinical trial protocol of human umbilical cord mesenchymal stem cells for the treatment of osteoarthritis of the knee joint. China Tissue Eng Res. 2018;22(09):1407\u201312.","journal-title":"China Tissue Eng Res"},{"issue":"14","key":"4184_CR85","first-page":"2216","volume":"19","author":"JJ Liang","year":"2015","unstructured":"Liang JJ, He ZY, Liu K, Li XL, Cheng WM, Yu XP, Chen ED. Intraarticular injection of autologous bone marrow mesenchymal stem cells for mild-to-moderate osteoarthritis. Chinese J Tissue Eng Res. 2015;19(14):2216.","journal-title":"Chinese J Tissue Eng Res"},{"issue":"2","key":"4184_CR86","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/S2665-9913(21)00326-X","volume":"4","author":"D Farge","year":"2022","unstructured":"Farge D, Loisel S, Resche-Rigon M, et al. Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1\/2 study. Lancet Rheumatol. 2022;4(2):e91\u2013104.","journal-title":"Lancet Rheumatol"},{"issue":"24","key":"4184_CR87","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1089\/scd.2013.0023","volume":"22","author":"L Wang","year":"2013","unstructured":"Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B, Li Y, Bai W, Li M, Ji H, Zhu D, Wu M, Liu Y. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(24):3192\u2013202. https:\/\/doi.org\/10.1089\/scd.2013.0023.","journal-title":"Stem Cells Dev"},{"key":"4184_CR88","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/164_2021_551","volume":"272","author":"A Jayatilleke","year":"2022","unstructured":"Jayatilleke A. Immunosuppression in rheumatologic and auto-immune disease. Handb Exp Pharmacol. 2022;272:181\u2013208. https:\/\/doi.org\/10.1007\/164_2021_551.","journal-title":"Handb Exp Pharmacol"},{"issue":"12","key":"4184_CR89","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.3390\/ijms19123851.m","volume":"19","author":"DR Neavin","year":"2018","unstructured":"Neavin DR, Liu D, Ray B, Weinshilboum RM. The role of the aryl hydrocarbon receptor (AHR) in immune and inflammatory diseases. Int J Mol Sci. 2018;19(12):3851. https:\/\/doi.org\/10.3390\/ijms19123851.m.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4184_CR90","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/biom11111624","volume":"11","author":"T Ao","year":"2021","unstructured":"Ao T, Kikuta J, Ishii M. The effects of vitamin D on immune system and inflammatory diseases. Biomolecules. 2021;11(11):1624. https:\/\/doi.org\/10.3390\/biom11111624.","journal-title":"Biomolecules"},{"issue":"12","key":"4184_CR91","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd.2017.201","volume":"16","author":"DM Schwartz","year":"2017","unstructured":"Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O\u2019Shea JJ. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov. 2017;16(12):843\u201362. https:\/\/doi.org\/10.1038\/nrd.2017.201.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"4184_CR92","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3390\/jcm10040711","volume":"10","author":"BC Lee","year":"2021","unstructured":"Lee BC, Kang I, Yu KR. therapeutic features and updated clinical trials of mesenchymal stem cell (MSC)-derived exosomes. J Clin Med. 2021;10(4):711. https:\/\/doi.org\/10.3390\/jcm10040711.","journal-title":"J Clin Med"},{"key":"4184_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101864","volume":"85","author":"B You","year":"2023","unstructured":"You B, Zhou C, Yang Y. MSC-EVs alleviate osteoarthritis by regulating microenvironmental cells in the articular cavity and maintaining cartilage matrix homeostasis. Ageing Res Rev. 2023;85: 101864. https:\/\/doi.org\/10.1016\/j.arr.2023.101864.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"4184_CR94","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13287-020-02090-y","volume":"12","author":"B Lv","year":"2021","unstructured":"Lv B, Zhang X, Yuan J, Chen Y, Ding H, Cao X, Huang A. Biomaterial-supported MSC transplantation enhances cell-cell communication for spinal cord injury. Stem Cell Res Ther. 2021;12(1):36. https:\/\/doi.org\/10.1186\/s13287-020-02090-y.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"4184_CR95","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41423-023-00998-y","volume":"20","author":"P Li","year":"2023","unstructured":"Li P, Ou Q, Shi S, Shao C. Immunomodulatory properties of mesenchymal stem cells\/dental stem cells and their therapeutic applications. Cell Mol Immunol. 2023;20(6):558\u201369. https:\/\/doi.org\/10.1038\/s41423-023-00998-y.","journal-title":"Cell Mol Immunol"},{"key":"4184_CR96","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fimmu.2019.00798","volume":"10","author":"N Luque-Campos","year":"2019","unstructured":"Luque-Campos N, Contreras-L\u00f3pez RA, Jose Paredes-Mart\u00ednez M, Torres MJ, Bahraoui S, Wei M, Espinoza F, Djouad F, Elizondo-Vega RJ, Luz-Crawford P. Mesenchymal stem cells improve rheumatoid arthritis progression by controlling memory T cell response. Front Immunol. 2019;10:798. https:\/\/doi.org\/10.3389\/fimmu.2019.00798.","journal-title":"Front Immunol"},{"key":"4184_CR97","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/nyas.12815","volume":"1351","author":"A Uccelli","year":"2015","unstructured":"Uccelli A, de Rosbo NK. The immunomodulatory function of mesenchymal stem cells: more of action and pathways. Ann NY Acad Sci. 2015;1351:114\u201326.","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"4184_CR98","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12015-020-09954-z","volume":"16","author":"A Karamini","year":"2020","unstructured":"Karamini A, Bakopoulou A, Andreadis D, Gkiouras K, Kritis A. Therapeutic potential of mesenchymal stromal stem cells in rheumatoid arthritis: a systematic review of in vivo studies. Stem Cell Rev Rep. 2020;16(2):276\u201387. https:\/\/doi.org\/10.1007\/s12015-020-09954-z.","journal-title":"Stem Cell Rev Rep"},{"issue":"8","key":"4184_CR99","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/cells9081852","volume":"9","author":"M Lopez-Santalla","year":"2020","unstructured":"Lopez-Santalla M, Fernandez-Perez R, Garin MI. Mesenchymal stem\/stromal cells for rheumatoid arthritis treatment: an update on clinical applications. Cells. 2020;9(8):1852. https:\/\/doi.org\/10.3390\/cells9081852.","journal-title":"Cells"},{"issue":"8","key":"4184_CR100","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/cells8080886","volume":"8","author":"Y Han","year":"2019","unstructured":"Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal stem cells for regenerative medicine. Cells. 2019;8(8):886. https:\/\/doi.org\/10.3390\/cells8080886.","journal-title":"Cells"},{"issue":"1","key":"4184_CR101","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trre.2012.11.003","volume":"27","author":"P Hematti","year":"2013","unstructured":"Hematti P, Kim J, Stein AP, Kaufman D. Potential role of mesenchymal stromal cells in pancreatic islet transplantation. Transplant Rev (Orlando). 2013;27(1):21\u20139. https:\/\/doi.org\/10.1016\/j.trre.2012.11.003.","journal-title":"Transplant Rev (Orlando)"},{"issue":"1","key":"4184_CR102","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107(1):367\u201372. https:\/\/doi.org\/10.1182\/blood-2005-07-2657.","journal-title":"Blood"},{"issue":"5","key":"4184_CR103","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/eji.200425405","volume":"35","author":"A Augello","year":"2005","unstructured":"Augello A, Tasso R, Negrini SM, Amateis A, Indiveri F, Cancedda R, Pennesi G. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol. 2005;35(5):1482\u201390. https:\/\/doi.org\/10.1002\/eji.200425405.","journal-title":"Eur J Immunol"},{"issue":"1","key":"4184_CR104","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/scd.2014.0155","volume":"24","author":"MM Rosado","year":"2015","unstructured":"Rosado MM, Bernardo ME, Scarsella M, Conforti A, Giorda E, Biagini S, Cascioli S, Rossi F, Guzzo I, Vivarelli M, Dello Strologo L, Emma F, Locatelli F, Carsetti R. Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells. Stem Cells Dev. 2015;24(1):93\u2013103. https:\/\/doi.org\/10.1089\/scd.2014.0155.","journal-title":"Stem Cells Dev"},{"issue":"7","key":"4184_CR105","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","volume":"17","author":"D Mauro","year":"2021","unstructured":"Mauro D, Thomas R, Guggino G, Lories R, Brown MA, Ciccia F. Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol. 2021;17(7):387\u2013404. https:\/\/doi.org\/10.1038\/s41584-021-00625-y.","journal-title":"Nat Rev Rheumatol"},{"key":"4184_CR106","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.12688\/f1000research.14956.1","volume":"7","author":"L Garcia-Montoya","year":"2018","unstructured":"Garcia-Montoya L, Gul H, Emery P. Recent advances in ankylosing spondylitis: understanding the disease and management. F1000Research. 2018;7:1512. https:\/\/doi.org\/10.12688\/f1000research.14956.1.","journal-title":"F1000Research"},{"issue":"3","key":"4184_CR107","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.3390\/ijms24032085.PMID:36768406;PMCID:PMC9916886","volume":"24","author":"H Cai","year":"2023","unstructured":"Cai H, Guo H. Mesenchymal stem cells and their exocytotic vesicles. Int J Mol Sci. 2023;24(3):2085. https:\/\/doi.org\/10.3390\/ijms24032085.PMID:36768406;PMCID:PMC9916886.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4184_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2023.152041","volume":"125","author":"J Gopalarethinam","year":"2023","unstructured":"Gopalarethinam J, Nair AP, Iyer M, Vellingiri B, Subramaniam MD. Advantages of mesenchymal stem cell over the other stem cells. Acta Histochem. 2023;125(4): 152041. https:\/\/doi.org\/10.1016\/j.acthis.2023.152041.","journal-title":"Acta Histochem"},{"key":"4184_CR109","doi-asserted-by":"publisher","first-page":"e2303388","DOI":"10.1002\/advs.202303388","volume":"11","author":"Z Su","year":"2023","unstructured":"Su Z, Li J, Lin J, Li Z, Che Y, Zhang Z, Zheng G, Ye G, Yu W, Zeng Y, Xu P, Xu X, Xie Z, Wu Y, Shen H. TNF-\u03b1-Induced KAT2A Impedes BMMSC Quiescence by mediating succinylation of the mitophagy-related protein VCP. Adv Sci (Weinh). 2023;11:e2303388. https:\/\/doi.org\/10.1002\/advs.202303388.","journal-title":"Adv Sci (Weinh)"},{"key":"4184_CR110","doi-asserted-by":"publisher","unstructured":"Li A. Clinical research on mesenchymal stem cell therapy for type 2 diabetes and ankylosing spondylitis. Shandong: Shandong University 2017. https:\/\/doi.org\/10.7666\/d.Y3336647.","DOI":"10.7666\/d.Y3336647"},{"issue":"10","key":"4184_CR111","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3727\/096368913X667727","volume":"23","author":"P Wang","year":"2014","unstructured":"Wang P, Li Y, Huang L, Yang J, Yang R, Deng W, Liang B, Dai L, Meng Q, Gao L, Chen X, Shen J, Tang Y, Zhang X, Hou J, Ye J, Chen K, Cai Z, Wu Y, Shen H. Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial. Cell Transplant. 2014;23(10):1293\u2013303. https:\/\/doi.org\/10.3727\/096368913X667727.","journal-title":"Cell Transplant"},{"key":"4184_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152498","volume":"68","author":"L Zeng","year":"2024","unstructured":"Zeng L, Yang K, Yu G, Chen J, Long Z, Xiang W, Liu S, Zheng Y, Yan Y, Hao M, Sun L. Efficacy and safety of culture-expanded mesenchymal stromal cell therapy in the treatment of 4 types of inflammatory arthritis: a systematic review and meta-analysis of 36 randomized controlled trials. Semin Arthritis Rheum. 2024;68: 152498. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152498.","journal-title":"Semin Arthritis Rheum"},{"key":"4184_CR113","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fimmu.2019.00266","volume":"10","author":"CL Ross","year":"2019","unstructured":"Ross CL, Ang DC, Almeida-Porada G. Targeting mesenchymal stromal cells\/pericytes (MSCs) with pulsed electromagnetic field (PEMF) has the potential to treat rheumatoid arthritis. Front Immunol. 2019;10:266. https:\/\/doi.org\/10.3389\/fimmu.2019.00266.","journal-title":"Front Immunol"},{"issue":"4","key":"4184_CR114","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1517\/14712598.2016.1145651","volume":"16","author":"D Reissis","year":"2016","unstructured":"Reissis D, Tang QO, Cooper NC, Carasco CF, Gamie Z, Mantalaris A, Tsiridis E. Current clinical evidence for the use of mesenchymal stem cells in articular cartilage repair. Expert Opin Biol Ther. 2016;16(4):535\u201357. https:\/\/doi.org\/10.1517\/14712598.2016.1145651.","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"4184_CR115","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1002\/art.30474","volume":"63","author":"GI MacDonald","year":"2011","unstructured":"MacDonald GI, Augello A, De Bari C. Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases. Arthritis Rheum. 2011;63(9):2547\u201357. https:\/\/doi.org\/10.1002\/art.30474.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4184_CR116","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12026-017-8973-4","volume":"66","author":"M Khosravi","year":"2018","unstructured":"Khosravi M, Bidmeshkipour A, Moravej A, Hojjat-Assari S, Naserian S, Karimi MH. Induction of CD4+CD25+Foxp3+ regulatory T cells by mesenchymal stem cells is associated with RUNX complex factors. Immunol Res. 2018;66(1):207\u201318. https:\/\/doi.org\/10.1007\/s12026-017-8973-4.","journal-title":"Immunol Res"},{"issue":"1","key":"4184_CR117","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10067-011-1816-0","volume":"31","author":"J Liang","year":"2012","unstructured":"Liang J, Li X, Zhang H, Wang D, Feng X, Wang H, Hua B, Liu B, Sun L. Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin Rheumatol. 2012;31(1):157\u201361. https:\/\/doi.org\/10.1007\/s10067-011-1816-0.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"4184_CR118","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.joca.2013.04.008","volume":"21","author":"AJ Roelofs","year":"2013","unstructured":"Roelofs AJ, Rocke JP, De Bari C. Cell-based approaches to joint surface repair: a research perspective. Osteoarthr Cartil. 2013;21(7):892\u2013900. https:\/\/doi.org\/10.1016\/j.joca.2013.04.008.","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"4184_CR119","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/rheumatology\/keu377","volume":"54","author":"OI Eseonu","year":"2015","unstructured":"Eseonu OI, De Bari C. Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis. Rheumatology (Oxford). 2015;54(2):210\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/keu377.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"4184_CR120","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","volume":"19","author":"JE Pope","year":"2023","unstructured":"Pope JE, Denton CP, Johnson SR, Fernandez-Codina A, Hudson M, Nevskaya T. State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol. 2023;19(4):212\u201326. https:\/\/doi.org\/10.1038\/s41584-023-00909-5.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"4184_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102755","volume":"20","author":"D Farge","year":"2021","unstructured":"Farge D, Loisel S, Lansiaux P, Tarte K. Mesenchymal stromal cells for systemic sclerosis treatment. Autoimmun Rev. 2021;20(3): 102755. https:\/\/doi.org\/10.1016\/j.autrev.2021.102755.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"4184_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102831","volume":"20","author":"CH Escobar-Soto","year":"2021","unstructured":"Escobar-Soto CH, Mejia-Romero R, Aguilera N, Alzate-Granados JP, Mendoza-Pinto C, Mungu\u00eda-Realpozo P, M\u00e9ndez-Mart\u00ednez S, Garc\u00eda-Carrasco M, Rojas-Villarraga A. Human mesenchymal stem cells for the management of systemic sclerosis. Syst Rev Autoimmun Rev. 2021;20(6): 102831. https:\/\/doi.org\/10.1016\/j.autrev.2021.102831.","journal-title":"Syst Rev Autoimmun Rev"},{"issue":"3","key":"4184_CR123","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12016-021-08892-z","volume":"64","author":"X Zhuang","year":"2023","unstructured":"Zhuang X, Hu X, Zhang S, Li X, Yuan X, Wu Y. Mesenchymal stem cell-based therapy as a new approach for the treatment of systemic sclerosis. Clin Rev Allergy Immunol. 2023;64(3):284\u2013320. https:\/\/doi.org\/10.1007\/s12016-021-08892-z.","journal-title":"Clin Rev Allergy Immunol"},{"key":"4184_CR124","doi-asserted-by":"publisher","first-page":"1125257","DOI":"10.3389\/fimmu.2023.1125257","volume":"14","author":"K Zhao","year":"2023","unstructured":"Zhao K, Kong C, Shi N, Jiang J, Li P. Potential angiogenic, immunomodulatory, and antifibrotic effects of mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis. Front Immunol. 2023;14:1125257. https:\/\/doi.org\/10.3389\/fimmu.2023.1125257.","journal-title":"Front Immunol"},{"issue":"1","key":"4184_CR125","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41392-023-01330-w","volume":"8","author":"Q Yao","year":"2023","unstructured":"Yao Q, Wu X, Tao C, Gong W, Chen M, Qu M, Zhong Y, He T, Chen S, Xiao G. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):56. https:\/\/doi.org\/10.1038\/s41392-023-01330-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"4184_CR126","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.joca.2021.03.002","volume":"30","author":"G Aubourg","year":"2022","unstructured":"Aubourg G, Rice SJ, Bruce-Wootton P, Loughlin J. Genetics of osteoarthritis. Osteoarthr Cartil. 2022;30(5):636\u201349. https:\/\/doi.org\/10.1016\/j.joca.2021.03.002.","journal-title":"Osteoarthr Cartil"},{"issue":"9","key":"4184_CR127","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.3390\/ijms23094642","volume":"23","author":"H Yu","year":"2022","unstructured":"Yu H, Huang T, Lu WW, Tong L, Chen D. Osteoarthritis pain. Int J Mol Sci. 2022;23(9):4642. https:\/\/doi.org\/10.3390\/ijms23094642.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4184_CR128","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.joca.2021.11.004","volume":"30","author":"DA Young","year":"2022","unstructured":"Young DA, Barter MJ, Soul J. Osteoarthritis year in review: genetics, genomics, epigenetics. Osteoarthr Cartil. 2022;30(2):216\u201325. https:\/\/doi.org\/10.1016\/j.joca.2021.11.004.","journal-title":"Osteoarthr Cartil"},{"issue":"5","key":"4184_CR129","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","volume":"18","author":"E Sanchez-Lopez","year":"2022","unstructured":"Sanchez-Lopez E, Coras R, Torres A, Lane NE, Guma M. Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol. 2022;18(5):258\u201375. https:\/\/doi.org\/10.1038\/s41584-022-00749-9.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"4184_CR130","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.joca.2022.10.004","volume":"31","author":"MA Holden","year":"2023","unstructured":"Holden MA, Nicolson PJA, Thomas MJ, Corp N, Hinman RS, Bennell KL. Osteoarthritis year in review 2022: rehabilitation. Osteoarthr Cartil. 2023;31(2):177\u201386. https:\/\/doi.org\/10.1016\/j.joca.2022.10.004.","journal-title":"Osteoarthr Cartil"},{"issue":"7","key":"4184_CR131","doi-asserted-by":"publisher","first-page":"6405","DOI":"10.3390\/ijms24076405","volume":"24","author":"R Giorgino","year":"2023","unstructured":"Giorgino R, Albano D, Fusco S, Peretti GM, Mangiavini L, Messina C. Knee osteoarthritis: epidemiology, pathogenesis, and mesenchymal stem cells: what else is new? An update. Int J Mol Sci. 2023;24(7):6405. https:\/\/doi.org\/10.3390\/ijms24076405.","journal-title":"Int J Mol Sci"},{"key":"4184_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101684","volume":"80","author":"H Yu","year":"2022","unstructured":"Yu H, Huang Y, Yang L. Research progress in the use of mesenchymal stem cells and their derived exosomes in the treatment of osteoarthritis. Ageing Res Rev. 2022;80: 101684. https:\/\/doi.org\/10.1016\/j.arr.2022.101684.","journal-title":"Ageing Res Rev"},{"issue":"9","key":"4184_CR133","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.3390\/ijms23094693","volume":"23","author":"L Ib\u00e1\u00f1ez","year":"2022","unstructured":"Ib\u00e1\u00f1ez L, Guillem-Llobat P, Mar\u00edn M, Guill\u00e9n MI. Connection between mesenchymal stem cells therapy and osteoclasts in osteoarthritis. Int J Mol Sci. 2022;23(9):4693. https:\/\/doi.org\/10.3390\/ijms23094693.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4184_CR134","first-page":"448","volume":"13","author":"C Zhu","year":"2021","unstructured":"Zhu C, Wu W, Qu X. Mesenchymal stem cells in osteoarthritis therapy: a review. Am J Transl Res. 2021;13(2):448\u201361.","journal-title":"Am J Transl Res"},{"issue":"1","key":"4184_CR135","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41584-023-01058-5","volume":"20","author":"JJE Koopman","year":"2024","unstructured":"Koopman JJE, Costenbader KH. Shifting the SLE management paradigm: challenges and implications. Nat Rev Rheumatol. 2024;20(1):5\u20136. https:\/\/doi.org\/10.1038\/s41584-023-01058-5.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4184_CR136","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/1744666X.2023.2260098","volume":"20","author":"H Ding","year":"2024","unstructured":"Ding H, Shen Y, Hong SM, Xiang C, Shen N. Biomarkers for systemic lupus erythematosus - a focus on organ damage. Expert Rev Clin Immunol. 2024;20(1):39\u201358. https:\/\/doi.org\/10.1080\/1744666X.2023.2260098.","journal-title":"Expert Rev Clin Immunol"},{"key":"4184_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.714832","volume":"12","author":"C Yang","year":"2021","unstructured":"Yang C, Sun J, Tian Y, Li H, Zhang L, Yang J, Wang J, Zhang J, Yan S, Xu D. Immunomodulatory effect of MSCs and MSCs-derived extracellular vesicles in systemic lupus erythematosus. Front Immunol. 2021;12: 714832. https:\/\/doi.org\/10.3389\/fimmu.2021.714832.","journal-title":"Front Immunol"},{"key":"4184_CR138","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/878535","volume":"2015","author":"H Rahavi","year":"2015","unstructured":"Rahavi H, Hashemi SM, Soleimani M, Mohammadi J, Tajik N. Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model. J Diabetes Res. 2015;2015: 878535. https:\/\/doi.org\/10.1155\/2015\/878535.","journal-title":"J Diabetes Res"},{"issue":"26","key":"4184_CR139","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","volume":"113","author":"GM Spaggiari","year":"2009","unstructured":"Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood. 2009;113(26):6576\u201383. https:\/\/doi.org\/10.1182\/blood-2009-02-203943.","journal-title":"Blood"},{"issue":"5","key":"4184_CR140","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.14336\/AD.2020.0711","volume":"11","author":"P Gentile","year":"2020","unstructured":"Gentile P, Sterodimas A, Pizzicannella J, Calabrese C, Garcovich S. Research progress on mesenchymal stem cells (MSCs), adipose-derived mesenchymal stem cells (AD-MSCs), drugs, and vaccines in inhibiting COVID-19 disease. Aging Dis. 2020;11(5):1191\u2013201. https:\/\/doi.org\/10.14336\/AD.2020.0711.","journal-title":"Aging Dis"},{"issue":"11","key":"4184_CR141","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3727\/096368914X685645","volume":"24","author":"MJ Park","year":"2015","unstructured":"Park MJ, Kwok SK, Lee SH, Kim EK, Park SH, Cho ML. Adipose tissue-derived mesenchymal stem cells induce expansion of interleukin-10-producing regulatory B cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus. Cell Transplant. 2015;24(11):2367\u201377. https:\/\/doi.org\/10.3727\/096368914X685645.","journal-title":"Cell Transplant"},{"key":"4184_CR142","first-page":"103","volume":"19","author":"E Tursun","year":"2019","unstructured":"Tursun E. Efficacy of applying umbilical cord mesenchymal stem cells combined with rituximab therapy in patients with systemic lupus erythematosus. World Digest Latest Med Info (Electron Ed). 2019;19:103.","journal-title":"World Digest Latest Med Info (Electron Ed)"},{"issue":"9","key":"4184_CR143","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/cdd.2012.26","volume":"19","author":"W Li","year":"2012","unstructured":"Li W, Ren G, Huang Y, Su J, Han Y, Li J, Chen X, Cao K, Chen Q, Shou P, Zhang L, Yuan ZR, Roberts AI, Shi S, Le AD, Shi Y. Mesenchymal stem cells: a double-edged sword in regulating immune responses. Cell Death Differ. 2012;19(9):1505\u201313. https:\/\/doi.org\/10.1038\/cdd.2012.26.","journal-title":"Cell Death Differ"},{"issue":"4","key":"4184_CR144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS ONE. 2010;5(4): e10088. https:\/\/doi.org\/10.1371\/journal.pone.0010088.","journal-title":"PLoS ONE"},{"issue":"5\u20136","key":"4184_CR145","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1159\/000178590","volume":"29","author":"S Ji","year":"2012","unstructured":"Ji S, Guo Q, Han Y, Tan G, Luo Y, Zeng F. Mesenchymal stem cell transplantation inhibits abnormal activation of Akt\/GSK3\u03b2 signaling pathway in T cells from systemic lupus erythematosus mice. Cell Physiol Biochem. 2012;29(5\u20136):705\u201312. https:\/\/doi.org\/10.1159\/000178590.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"4184_CR146","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00393-018-0450-5","volume":"78","author":"W Zhang","year":"2019","unstructured":"Zhang W, Feng YL, Pang CY, Lu FA, Wang YF. Transplantation of adipose tissue-derived stem cells ameliorates autoimmune pathogenesis in MRL\/lpr mice: modulation of the balance between Th17 and Treg. Z Rheumatol. 2019;78(1):82\u20138. https:\/\/doi.org\/10.1007\/s00393-018-0450-5.","journal-title":"Z Rheumatol"},{"issue":"12","key":"4184_CR147","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3727\/096368912X658692","volume":"22","author":"X Ma","year":"2013","unstructured":"Ma X, Che N, Gu Z, Huang J, Wang D, Liang J, Hou Y, Gilkeson G, Lu L, Sun L. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplant. 2013;22(12):2279\u201390. https:\/\/doi.org\/10.3727\/096368912X658692.","journal-title":"Cell Transplant"},{"issue":"12","key":"4184_CR148","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3727\/096368911X582769c","volume":"22","author":"D Wang","year":"2013","unstructured":"Wang D, Zhang H, Liang J, Li X, Feng X, Wang H, Hua B, Liu B, Lu L, Gilkeson GS, Silver RM, Chen W, Shi S, Sun L. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant. 2013;22(12):2267\u201377. https:\/\/doi.org\/10.3727\/096368911X582769c.","journal-title":"Cell Transplant"},{"issue":"3","key":"4184_CR149","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.pop.2023.03.009","volume":"50","author":"LP Bruner","year":"2023","unstructured":"Bruner LP, White AM, Proksell S. Inflammatory bowel disease. Prim Care. 2023;50(3):411\u201327. https:\/\/doi.org\/10.1016\/j.pop.2023.03.009.","journal-title":"Prim Care"},{"issue":"6","key":"4184_CR150","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S2468-1253(23)00011-0","volume":"8","author":"S Massironi","year":"2023","unstructured":"Massironi S, Vigan\u00f2 C, Palermo A, Pirola L, Mulinacci G, Allocca M, Peyrin-Biroulet L, Danese S. Inflammation and malnutrition in inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2023;8(6):579\u201390. https:\/\/doi.org\/10.1016\/S2468-1253(23)00011-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"4184_CR151","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/med.21893","volume":"42","author":"D Liu","year":"2022","unstructured":"Liu D, Saikam V, Skrada KA, Merlin D, Iyer SS. Inflammatory bowel disease biomarkers. Med Res Rev. 2022;42(5):1856\u201387. https:\/\/doi.org\/10.1002\/med.21893.","journal-title":"Med Res Rev"},{"issue":"10","key":"4184_CR152","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ueg2.12319","volume":"10","author":"N Singh","year":"2022","unstructured":"Singh N, Bernstein CN. Environmental risk factors for inflammatory bowel disease. United European Gastroenterol J. 2022;10(10):1047\u201353. https:\/\/doi.org\/10.1002\/ueg2.12319.","journal-title":"United European Gastroenterol J"},{"issue":"11","key":"4184_CR153","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41575-022-00634-6","volume":"19","author":"TH Bisgaard","year":"2022","unstructured":"Bisgaard TH, Allin KH, Keefer L, Ananthakrishnan AN, Jess T. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat Rev Gastroenterol Hepatol. 2022;19(11):717\u201326. https:\/\/doi.org\/10.1038\/s41575-022-00634-6.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"20","key":"4184_CR154","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.3390\/nu14204261","volume":"14","author":"M Godala","year":"2022","unstructured":"Godala M, Gaszy\u0144ska E, Zatorski H, Ma\u0142ecka-Wojciesko E. Dietary interventions in inflammatory bowel disease. Nutrients. 2022;14(20):4261. https:\/\/doi.org\/10.3390\/nu14204261.","journal-title":"Nutrients"},{"issue":"10","key":"4184_CR155","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/ueg2.12317","volume":"10","author":"M Agrawal","year":"2022","unstructured":"Agrawal M, Jess T. Implications of the changing epidemiology of inflammatory bowel disease in a changing world. United Eur Gastroenterol J. 2022;10(10):1113\u201320. https:\/\/doi.org\/10.1002\/ueg2.12317.","journal-title":"United Eur Gastroenterol J"},{"issue":"3","key":"4184_CR156","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41575-021-00543-0","volume":"19","author":"S D'Alessio","year":"2022","unstructured":"D\u2019Alessio S, Ungaro F, Noviello D, Lovisa S, Peyrin-Biroulet L, Danese S. Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nat Rev Gastroenterol Hepatol. 2022;19(3):169\u201384. https:\/\/doi.org\/10.1038\/s41575-021-00543-0.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"4184_CR157","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/jgh3.12141","volume":"3","author":"R Ciccocioppo","year":"2019","unstructured":"Ciccocioppo R, Klersy C, Leffler DA, Rogers R, Bennett D, Corazza GR. Systematic review with meta-analysis: safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas. JGH Open. 2019;3(3):249\u201360. https:\/\/doi.org\/10.1002\/jgh3.12141.","journal-title":"JGH Open"},{"issue":"1","key":"4184_CR158","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13287-022-02811-5","volume":"13","author":"G Guo","year":"2022","unstructured":"Guo G, Tan Z, Liu Y, Shi F, She J. The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer. Stem Cell Res Ther. 2022;13(1):138. https:\/\/doi.org\/10.1186\/s13287-022-02811-5.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"4184_CR159","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/ecco-jcc\/jjac144","volume":"17","author":"S Furukawa","year":"2023","unstructured":"Furukawa S, Mizushima T, Nakaya R, Shibata M, Yamaguchi T, Watanabe K, Futami K. Darvadstrocel for complex perianal fistulas in Japanese adults with Crohn\u2019s disease: a phase 3 study. J Crohns Colitis. 2023;17(3):369\u201378. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac144.","journal-title":"J Crohns Colitis"},{"issue":"11","key":"4184_CR160","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/ibd\/izab361","volume":"28","author":"J Pan\u00e9s","year":"2022","unstructured":"Pan\u00e9s J, Bouma G, Ferrante M, Kucharzik T, Nachury M, de la Portilla F, de Juan W, Reinisch FS, Tschmelitsch J, Brett NR, Ladouceur M, Binek M, Hantsbarger G, Campbell-Hill S, Karki C, Buskens C. INSPECT: a retrospective study to evaluate long-term effectiveness and safety of darvadstrocel in patients with perianal fistulizing Crohn\u2019s disease treated in the ADMIRE-CD Trial. Inflammat Bowel Dis. 2022;28(11):1737\u201345. https:\/\/doi.org\/10.1093\/ibd\/izab361.","journal-title":"Inflammat Bowel Dis"},{"issue":"6","key":"4184_CR161","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.mayocp.2015.03.023","volume":"90","author":"R Ciccocioppo","year":"2015","unstructured":"Ciccocioppo R, Gallia A, Sgarella A, Kruzliak P, Gobbi PG, Corazza GR. Long-Term Follow-up of crohn disease fistulas after local injections of bone marrow-derived mesenchymal stem cells. Mayo Clin Proc. 2015;90(6):747\u201355. https:\/\/doi.org\/10.1016\/j.mayocp.2015.03.023.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"4184_CR162","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J, Marrie RA, Xavier Montalban V, Yong W, Thompson AJ, Reich DS. International advisory committee on clinical trials in multiple sclerosis. Multiple sclerosis progression: time for a new mechanism-driven framework. The Lancet Neurology. 2023;22(1):78\u201388. https:\/\/doi.org\/10.1016\/S1474-4422(22)00289-7.","journal-title":"The Lancet Neurology"},{"issue":"1","key":"4184_CR163","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","volume":"22","author":"JS Graves","year":"2023","unstructured":"Graves JS, Krysko KM, Hua LH, Absinta M, Franklin RJM, Segal BM. Ageing and multiple sclerosis. Lancet Neurol. 2023;22(1):66\u201377. https:\/\/doi.org\/10.1016\/S1474-4422(22)00184-3.","journal-title":"Lancet Neurol"},{"issue":"1","key":"4184_CR164","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2217\/nmt-2021-0058","volume":"13","author":"M Amin","year":"2023","unstructured":"Amin M, Hersh CM. Updates and advances in multiple sclerosis neurotherapeutics. Neurodegener Dis Manag. 2023;13(1):47\u201370. https:\/\/doi.org\/10.2217\/nmt-2021-0058.","journal-title":"Neurodegener Dis Manag"},{"issue":"9","key":"4184_CR165","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S1474-4422(22)00255-1","volume":"21","author":"A Goris","year":"2022","unstructured":"Goris A, Vandebergh M, McCauley JL, Saarela J, Cotsapas C. Genetics of multiple sclerosis: lessons from polygenicity. Lancet Neurol. 2022;21(9):830\u201342. https:\/\/doi.org\/10.1016\/S1474-4422(22)00255-1.","journal-title":"Lancet Neurol"},{"issue":"20","key":"4184_CR166","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1001\/jama.2022.14236","volume":"328","author":"R Marcus","year":"2022","unstructured":"Marcus R. What is multiple sclerosis? JAMA. 2022;328(20):2078. https:\/\/doi.org\/10.1001\/jama.2022.14236.","journal-title":"JAMA"},{"key":"4184_CR167","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","volume":"17","author":"S Rodr\u00edguez Mur\u00faa","year":"2022","unstructured":"Rodr\u00edguez Mur\u00faa S, Farez MF, Quintana FJ. The immune response in multiple sclerosis. Annu Rev Pathol. 2022;17:121\u201339. https:\/\/doi.org\/10.1146\/annurev-pathol-052920-040318.","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"4184_CR168","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s10571-023-01344-6","volume":"43","author":"E Cecerska-Hery\u0107","year":"2023","unstructured":"Cecerska-Hery\u0107 E, P\u0119ka\u0142a M, Serwin N, Gli\u017aniewicz M, Grygorcewicz B, Michalczyk A, Hery\u0107 R, Budkowska M, Do\u0142\u0119gowska B. The use of stem cells as a potential treatment method for selected neurodegenerative diseases: review. Cell Mol Neurobiol. 2023;43(6):2643\u201373. https:\/\/doi.org\/10.1007\/s10571-023-01344-6.","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"4184_CR169","first-page":"24","volume":"8","author":"A Dulamea","year":"2015","unstructured":"Dulamea A. Mesenchymal stem cells in multiple sclerosis - translation to clinical trials. J Med Life. 2015;8(1):24\u20137.","journal-title":"J Med Life"},{"issue":"4","key":"4184_CR170","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/1352458509359727","volume":"16","author":"MS Freedman","year":"2010","unstructured":"Freedman MS, Bar-Or A, Atkins HL, Karussis D, Frassoni F, Lazarus H, Scolding N, Slavin S, Le Blanc K, Uccelli A. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Mul Scler J. 2010;16(4):503\u201310. https:\/\/doi.org\/10.1177\/1352458509359727.","journal-title":"Mul Scler J"},{"issue":"7","key":"4184_CR171","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/stem.1118","volume":"30","author":"L von Bahr","year":"2012","unstructured":"von Bahr L, Batsis I, Moll G, H\u00e4gg M, Szakos A, Sundberg B, Uzunel M, Ringden O, Le Blanc K. Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells. 2012;30(7):1575\u20138. https:\/\/doi.org\/10.1002\/stem.1118.","journal-title":"Stem Cells"},{"issue":"2","key":"4184_CR172","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/08820139.2018.1504301","volume":"48","author":"MA Sahraian","year":"2019","unstructured":"Sahraian MA, Mohyeddin Bonab M, Baghbanian SM, Owji M, Naser MA. Therapeutic use of intrathecal mesenchymal stem cells in patients with multiple sclerosis: a pilot study with booster injection. Immunol Invest. 2019;48(2):160\u20138. https:\/\/doi.org\/10.1080\/08820139.2018.1504301.","journal-title":"Immunol Invest"},{"issue":"1\u20132","key":"4184_CR173","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.07.013","volume":"227","author":"B Yamout","year":"2010","unstructured":"Yamout B, Hourani R, Salti H, Barada W, El-Hajj T, Al-Kutoubi A, Herlopian A, Baz EK, Mahfouz R, Khalil-Hamdan R, Kreidieh NM, El-Sabban M, Bazarbachi A. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J Neuroimmunol. 2010;227(1\u20132):185\u20139. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.07.013.","journal-title":"J Neuroimmunol"},{"issue":"18","key":"4184_CR174","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1089\/scd.2015.0008","volume":"24","author":"H Munir","year":"2015","unstructured":"Munir H, McGettrick HM. Mesenchymal stem cell therapy for autoimmune disease: risks and rewards. Stem Cells Dev. 2015;24(18):2091\u2013100. https:\/\/doi.org\/10.1089\/scd.2015.0008.","journal-title":"Stem Cells Dev"},{"key":"4184_CR175","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/5584_2018_247","volume":"1084","author":"B Genc","year":"2019","unstructured":"Genc B, Bozan HR, Genc S, Genc K. Stem cell therapy for multiple sclerosis. Adv Exp Med Biol. 2019;1084:145\u201374. https:\/\/doi.org\/10.1007\/5584_2018_247.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"4184_CR176","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2174\/157488812804484648","volume":"7","author":"MM Bonab","year":"2012","unstructured":"Bonab MM, Sahraian MA, Aghsaie A, Karvigh SA, Hosseinian SM, Nikbin B, Lotfi J, Khorramnia S, Motamed MR, Togha M, Harirchian MH, Moghadam NB, Alikhani K, Yadegari S, Jafarian S, Gheini MR. Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study. Curr Stem Cell Res Ther. 2012;7(6):407\u201314. https:\/\/doi.org\/10.2174\/157488812804484648.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"5","key":"4184_CR177","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/1352458509104590","volume":"15","author":"J Liang","year":"2009","unstructured":"Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun L. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler. 2009;15(5):644\u20136. https:\/\/doi.org\/10.1177\/1352458509104590.","journal-title":"Mult Scler"},{"issue":"Suppl 1","key":"4184_CR178","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.3727\/096368914X685005","volume":"23","author":"JF Li","year":"2014","unstructured":"Li JF, Zhang DJ, Geng T, Chen L, Huang H, Yin HL, Zhang YZ, Lou JY, Cao B, Wang YL. The potential of human umbilical cord-derived mesenchymal stem cells as a novel cellular therapy for multiple sclerosis. Cell Transplant. 2014;23(Suppl 1):S113\u201322. https:\/\/doi.org\/10.3727\/096368914X685005.","journal-title":"Cell Transplant"},{"issue":"5","key":"4184_CR179","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4161\/cam.26941","volume":"7","author":"ZL Hou","year":"2013","unstructured":"Hou ZL, Liu Y, Mao XH, Wei CY, Meng MY, Liu YH, Zhuyun Yang Z, Zhu H, Short M, Bernard C, Xiao ZC. Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis. Cell Adh Migr. 2013;7(5):404\u20137. https:\/\/doi.org\/10.4161\/cam.26941.","journal-title":"Cell Adh Migr"},{"issue":"1","key":"4184_CR180","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12967-018-1433-7","volume":"16","author":"NH Riordan","year":"2018","unstructured":"Riordan NH, Morales I, Fern\u00e1ndez G, Allen N, Fearnot NE, Leckrone ME, Markovich DJ, Mansfield D, Avila D, Patel AN, Kesari S, Paz RJ. Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis. J Transl Med. 2018;16(1):57. https:\/\/doi.org\/10.1186\/s12967-018-1433-7.","journal-title":"J Transl Med"},{"issue":"5","key":"4184_CR181","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/rheumatology\/kez142","volume":"60","author":"RI Fox","year":"2021","unstructured":"Fox RI, Fox CM, Gottenberg JE, D\u00f6rner T. Treatment of Sj\u00f6gren\u2019s syndrome: current therapy and future directions. Rheumatology (Oxford). 2021;60(5):2066\u201374. https:\/\/doi.org\/10.1093\/rheumatology\/kez142.","journal-title":"Rheumatology (Oxford)"},{"key":"4184_CR182","doi-asserted-by":"publisher","first-page":"1093924","DOI":"10.3389\/fphar.2023.1093924","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang X, Lin X, Su Y, Wang H. Systematic review with meta-analysis: efficacy and safety of biological treatment on salivary gland function in primary Sj\u00f6gren\u2019s syndrome. Front Pharmacol. 2023;14:1093924. https:\/\/doi.org\/10.3389\/fphar.2023.1093924.","journal-title":"Front Pharmacol"},{"issue":"7","key":"4184_CR183","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1093\/rheumatology\/kez004","volume":"60","author":"GM Verstappen","year":"2021","unstructured":"Verstappen GM, Kroese FGM, Bootsma H. T cells in primary Sj\u00f6gren\u2019s syndrome: targets for early intervention. Rheumatology (Oxford). 2021;60(7):3088\u201398. https:\/\/doi.org\/10.1093\/rheumatology\/kez004.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"4184_CR184","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.55563\/clinexprheumatol\/43z8gu","volume":"40","author":"V Manfr\u00e8","year":"2022","unstructured":"Manfr\u00e8 V, Chatzis LG, Cafaro G, Fonzetti S, Calvacchi S, Fulvio G, Navarro Garcia IC, La Rocca G, Ferro F, Perricone C, Bartoloni E, Baldini C. Sj\u00f6gren\u2019s syndrome: one year in review 2022. Clin Exp Rheumatol. 2022;40(12):2211\u201324. https:\/\/doi.org\/10.55563\/clinexprheumatol\/43z8gu.","journal-title":"Clin Exp Rheumatol"},{"key":"4184_CR185","doi-asserted-by":"publisher","first-page":"4357865","DOI":"10.1155\/2018\/4357865","volume":"2018","author":"W Chen","year":"2018","unstructured":"Chen W, Yu Y, Ma J, Olsen N, Lin J. Mesenchymal stem cells in primary Sj\u00f6gren\u2019s syndrome: prospective and challenges. Stem Cells Int. 2018;2018:4357865. https:\/\/doi.org\/10.1155\/2018\/4357865.","journal-title":"Stem Cells Int"},{"issue":"1","key":"4184_CR186","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13287-018-1023-x","volume":"9","author":"B Shi","year":"2018","unstructured":"Shi B, Qi J, Yao G, Feng R, Zhang Z, Wang D, Chen C, Tang X, Lu L, Chen W, Sun L. Mesenchymal stem cell transplantation ameliorates Sj\u00f6gren\u2019s syndrome via suppressing IL-12 production by dendritic cells. Stem Cell Res Ther. 2018;9(1):308. https:\/\/doi.org\/10.1186\/s13287-018-1023-x.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"4184_CR187","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.3892\/etm.2017.4313","volume":"13","author":"GF Ruan","year":"2017","unstructured":"Ruan GF, Zheng L, Huang JS, Huang WX, Gong BD, Fang XX, Zhang XY, Tang JP. Effect of mesenchymal stem cells on Sj\u00f6gren-like mice and the microRNA expression profiles of splenic CD4+ T cells. Exp Ther Med. 2017;13(6):2828\u201338. https:\/\/doi.org\/10.3892\/etm.2017.4313.","journal-title":"Exp Ther Med"},{"issue":"2","key":"4184_CR188","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrrheum.2013.166","volume":"10","author":"A Tyndall","year":"2014","unstructured":"Tyndall A. Mesenchymal stem cell treatments in rheumatology: a glass half full? Nat Rev Rheumatol. 2014;10(2):117\u201324. https:\/\/doi.org\/10.1038\/nrrheum.2013.166.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4184_CR189","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s13287-021-02541-0","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, Xing Y, Gan Y, He J, Hua H. Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine sj\u00f6gren\u2019s syndrome by modulating the balance of Treg and Th17 cells. Stem Cell Res Ther. 2021;12(1):478. https:\/\/doi.org\/10.1186\/s13287-021-02541-0.","journal-title":"Stem Cell Res Ther"},{"issue":"26","key":"4184_CR190","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.7150\/thno.37351","volume":"9","author":"G Yao","year":"2019","unstructured":"Yao G, Qi J, Liang J, Shi B, Chen W, Li W, Tang X, Wang D, Lu L, Chen W, Shi S, Hou Y, Sun L. Mesenchymal stem cell transplantation alleviates experimental Sj\u00f6gren\u2019s syndrome through IFN-\u03b2\/IL-27 signaling axis. Theranostics. 2019;9(26):8253\u201365. https:\/\/doi.org\/10.7150\/thno.37351.","journal-title":"Theranostics"},{"issue":"1","key":"4184_CR191","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/14397595.2019.1707996","volume":"31","author":"Y Liu","year":"2021","unstructured":"Liu Y, Li C, Wang S, Guo J, Guo J, Fu J, Ren L, An Y, He J, Li Z. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sj\u00f6gren\u2019s syndrome by inducing regulatory T cells. Mod Rheumatol. 2021;31(1):186\u201396. https:\/\/doi.org\/10.1080\/14397595.2019.1707996.","journal-title":"Mod Rheumatol"},{"key":"4184_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.604607","volume":"11","author":"J Tian","year":"2020","unstructured":"Tian J, Hong Y, Zhu Q, Zhou H, Zhang Y, Shen Z, Guo H, Zhang Y, Ai X, Zhao F, Rui K, Xu H, Wang S. Mesenchymal stem cell enhances the function of MDSCS in experimental Sj\u00f6gren syndrome. Front Immunol. 2020;11: 604607. https:\/\/doi.org\/10.3389\/fimmu.2020.604607.","journal-title":"Front Immunol"},{"issue":"1","key":"4184_CR193","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13287-021-02236-6","volume":"12","author":"M Matsumura-Kawashima","year":"2021","unstructured":"Matsumura-Kawashima M, Ogata K, Moriyama M, Murakami Y, Kawado T, Nakamura S. Secreted factors from dental pulp stem cells improve Sj\u00f6gren\u2019s syndrome via regulatory T cell-mediated immunosuppression. Stem Cell Res Ther. 2021;12(1):182. https:\/\/doi.org\/10.1186\/s13287-021-02236-6.","journal-title":"Stem Cell Res Ther"},{"issue":"15","key":"4184_CR194","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","volume":"120","author":"J Xu","year":"2012","unstructured":"Xu J, Wang D, Liu D, Fan Z, Zhang H, Liu O, Ding G, Gao R, Zhang C, Ding Y, Bromberg JS, Chen W, Sun L, Wang S. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome. Blood. 2012;120(15):3142\u201351. https:\/\/doi.org\/10.1182\/blood-2011-11-391144.","journal-title":"Blood"},{"issue":"4","key":"4184_CR195","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2217\/imt-2021-0174","volume":"14","author":"D Gen\u00e7","year":"2022","unstructured":"Gen\u00e7 D, G\u00fcnayd\u0131n B, Sezgin S, Alada\u011f A, Tarhan EF. Immunoregulatory effects of dental mesenchymal stem cells on T and B lymphocyte responses in primary Sj\u00f6gren\u2019s syndrome. Immunotherapy. 2022;14(4):225\u201347. https:\/\/doi.org\/10.2217\/imt-2021-0174.","journal-title":"Immunotherapy"},{"issue":"5","key":"4184_CR196","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266137","volume":"17","author":"D Gen\u00e7","year":"2022","unstructured":"Gen\u00e7 D, Bulut O, G\u00fcnaydin B, G\u00f6ksu M, D\u00fczg\u00fcn M, Dere Y, Sezgin S, Alada\u011f A, B\u00fclb\u00fcl A. Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sj\u00f6gren\u2019s syndrome murine model. PLoS ONE. 2022;17(5): e0266137. https:\/\/doi.org\/10.1371\/journal.pone.0266137.","journal-title":"PLoS ONE"},{"issue":"5","key":"4184_CR197","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/JLB.6MA0921-752RR","volume":"111","author":"N Yang","year":"2022","unstructured":"Yang N, Liu X, Chen X, Yu S, Yang W, Liu Y. Stem cells from exfoliated deciduous teethtransplantation ameliorates Sjogren\u2019s syndrome by secreting soluble Pd-L1. J Leukoc Biol. 2022;111(5):1043\u201355.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"4184_CR198","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1111\/odi.13113","volume":"25","author":"ZH Du","year":"2019","unstructured":"Du ZH, Ding C, Zhang Q, Zhang Y, Ge XY, Li SL, Yu GY. Stem cells fromexfoliateddeciduous teeth alleviate hyposalivation caused by Sjogren syndrome. Oral Dis. 2019;25(6):1530\u201344.","journal-title":"Oral Dis"},{"key":"4184_CR199","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888949","volume":"13","author":"N Li","year":"2022","unstructured":"Li N, Gao Z, Zhao L, Du B, Ma B, Nian H, Wei R. MSC-derived small extracellular vesicles attenuate autoimmune dacryoadenitis by promoting M2 macrophage polarization and inducing tregs via miR-100-5p. Front Immunol. 2022;13: 888949. https:\/\/doi.org\/10.3389\/fimmu.2022.888949.","journal-title":"Front Immunol"},{"key":"4184_CR200","doi-asserted-by":"publisher","unstructured":"Chinese Medical Association Rheumatology Branch, Chinese Hospital Association Clinical New Technology Application Professional Committee. Expert consensus on allogeneic mesenchymal stem cells in the treatment of systemic lupus erythematosus. Chinese J Rheumatol, 2022, 26(1): 1\u20138. https:\/\/doi.org\/10.3760\/cma.j.cn141217-20210923-00381","DOI":"10.3760\/cma.j.cn141217-20210923-00381"},{"issue":"3","key":"4184_CR201","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10067-024-06865-z","volume":"43","author":"M Alip","year":"2024","unstructured":"Alip M, Wang D, Zhao S, Li S, Zhang D, Duan X, Wang S, Hua B, Wang H, Zhang H, Feng X, Sun L. Umbilical cord mesenchymal stem cells transplantation in patients with systemic sclerosis: a 5-year follow-up study. Clin Rheumatol. 2024;43(3):1073\u201382. https:\/\/doi.org\/10.1007\/s10067-024-06865-z.","journal-title":"Clin Rheumatol"},{"issue":"2019","key":"4184_CR202","doi-asserted-by":"publisher","first-page":"7061408","DOI":"10.1155\/2019\/7061408","volume":"2","author":"L Wen","year":"2019","unstructured":"Wen L, Labopin M, Badoglio M, Wang D, Sun L, Farge-Bancel D. Prognostic factors for clinical response in systemic lupus erythematosus patients treated by allogeneic mesenchymal stem cells. Stem Cells Int. 2019;2(2019):7061408. https:\/\/doi.org\/10.1155\/2019\/7061408.","journal-title":"Stem Cells Int"},{"issue":"1","key":"4184_CR203","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s13287-022-03054-0","volume":"13","author":"R Margiana","year":"2022","unstructured":"Margiana R, Markov A, Zekiy AO, Hamza MU, Al-Dabbagh KA, Al-Zubaidi SH, Hameed NM, Ahmad I, Sivaraman R, Kzar HH, Al-Gazally ME, Mustafa YF, Siahmansouri H. Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review. Stem Cell Res Ther. 2022;13(1):366. https:\/\/doi.org\/10.1186\/s13287-022-03054-0.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"4184_CR204","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.2174\/1574888X17666220520155212","volume":"18","author":"A Wang","year":"2023","unstructured":"Wang A, Zhang L, Zhao M, Yu H. Quality control analysis of mesenchymal stem\/stromal cells during investigational new drug application for GvHD administration in China. Curr Stem Cell Res Ther. 2023;18(8):1032\u201340. https:\/\/doi.org\/10.2174\/1574888X17666220520155212.","journal-title":"Curr Stem Cell Res Ther"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04184-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04184-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04184-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T13:15:29Z","timestamp":1739279729000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04184-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":204,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4184"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04184-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}